Clinical observation of the role of gabexate mesylate in treatment of choledocholithiasis
- Received Date: 2010-06-22
- Rev Recd Date: 2011-09-19
-
Key words:
- gabexate /
- choledocholithiasis /
- sphincter of Oddi
Abstract: Objective To confirm the effect of gabexate mesylate on eliminating choledocholithiasis. Methods By simple randomization, the patients were assigned control group (not use gabexate), regular dosage group and high dosage group. The difference between every group on effect of eliminating choledocholithiasis by nonsurgical operation was observed. Results No significant different was found between regular dosage group and control group (P>0.05). There was a significant different between regular dosage group and high dosage group (P<0.05). Conclusion Gabexate mesylate had the effect of eliminating choledocholithiasis.
Citation: | CHEN Wei-chen, XUE Bin, LI Zhi-chen. Clinical observation of the role of gabexate mesylate in treatment of choledocholithiasis[J]. Journal of Pharmaceutical Practice and Service, 2011, 29(6): 449-450. |